@gline
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
CEO @Roivant, improving the delivery of healthcare to patients by treating every inefficiency as an opportunity
Joined November 2008
- Tweets111
- Following180
- Followers1.3K
- Likes142
Matt Gline retweeted
๐๐๐-๐๐๐ซ๐ ๐๐ญ ๐๐๐๐๐๐ญ๐ฌ: @BridgeBioPharma Founder & CEO Neil Kumar and @Roivant CEO @gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV
Watch the full episode: biotechtv.com/post/off-targeโฆ
This was a great conversation! Thanks @JMaraganore!
๐๐๐-๐๐๐ซ๐ ๐๐ญ ๐๐๐๐๐๐ญ๐ฌ: @JMaraganore has been a champion of innovation throughout his career. He and @gline discuss the road to success at @Alnylam, today's environment, and keeping the U.S. on top.
Watch the episode: biotechtv.com/post/off-targeโฆ
Congrats @bradloncar!
This was a fun one, @adamfeuerstein!
๐๐๐-๐๐๐ซ๐ ๐๐ญ ๐๐๐๐๐๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐ญ ๐๐ฅ๐ข๐ง๐: @gline speaks with @statnews' @adamfeuerstein about the dynamics of biotech journalism and how it compares to other industries.
Full video: biotechtv.com/post/off-targeโฆ
This was a fun conversation! Thanks Behzad, @bradloncar and @BiotechTVHQ
๐๐๐-๐๐๐ซ๐ ๐๐ญ ๐๐๐๐๐๐ญ๐ฌ: @gline speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector.
Full video: biotechtv.com/post/behzad-agโฆ
Matt Gline retweeted
๐๐จ๐ฆ๐จ๐ซ๐ซ๐จ๐ฐ: Tune in tomorrow for a new episode of Off-Target Effects with @gline. Matt interviews Avoro Capital's Behzad Aghazadeh.
Big Pharma's taking a breather on public M&A after a $50b deal streak at the end of last year. Overall biotech M&A is down but the value of deals involving private biotechs is up almost 200%, according to data compiled by Bloomberg.
bloomberg.com/news/articles/โฆ
No shame in coming behind Dave Ricks. @adamfeuerstein thanks for including us!
Thanks for having me over @AndrewE_Dunn! It was a lot of fun!
New: Check the latest entrant into Endpointsโ Slack room: Roivant CEO Matt Gline
Hot off a $7.1B deal with Roche, we talked dealmaking, biotech markets, Vivekโs presidential run, Lehman Brothers days, and much more:
endpts.com/the-endpoints-slaโฆ
Matt Gline retweeted
The Roivant team had an amazing day at @ENYFARMS for our annual NYC Roivant Day of Service! Thanks to all those who participated! #CommunityService #BuildingCommunity #Gardening #NYC
Matt Gline retweeted
People like to talk about the importance of "vision," but ultimately running a startup is like doing science: you have to follow the truth wherever it leads. Vision is only valuable insofar as it predicts where you'll find truth.
Matt Gline retweeted
โWeโre incredibly honored to receive this recognition. Roivant has always prided itself not only on our innovative business model but also on our commitment to fostering a culture that challenges convention and drives transformative change in the #biopharma industry,โ@gline
Fast Company's fifth annual Best Workplaces for Innovators list, created in collaboration with @Accenture, recognizes companies that understand vitally important breakthroughs can occur on the loading dock, not just in a corner office. โ
โ
Likewise, no single company has a monopoly on innovation: Five of the top 10 companies on this year's list are based outside of the U.S., including design democratizer Canva and engineering powerhouse Siemens, the only company to have appeared on Best Workplaces for Innovators all five years. โ
โ
See all the best workplaces here: bit.ly/3BwJvF2
#FCBestWorkplaces
Matt Gline retweeted
Read why our CEO @gline says: "I came to realize that at least some people โ and I put myself in this category โ really thrive when our back is to the wall and thereโs no way out but through.โ #leadership #biotech #partnership #pharma invivo.pharmaintelligence.inโฆ
Matt Gline retweeted
"Many of our best people at Roivant are deeply, innately curious, and I think itโs important to nurture that curiosity โ about the science, about the business, about why things are the way they are and whether thereโs a better way.โ @gline #biotech #leader bit.ly/420u42l
Matt Gline retweeted
We are excited to announce a new ADAR1 focused drug discovery collaboration with leading pharma company Boehringer Ingelheim. @Boehringer @Roivant globenewswire.com/news-releaโฆ
Matt Gline retweeted
Incyteโs Opzelura cream may be looking at a new competitive rival in the lucrative atopic dermatitis field.
loom.ly/9ULV12Y
Matt Gline retweeted
As we reflect on the many contributions that women have made in #biotech, including Rosalind Frank who played a fundamental role in deciphering the structure of DNA, we want to say thank you to all of the women at Roivant Sciences. #InternationalWomensDay #womenshistorymonth2023
Thanks for having me @rahulc!
Join @gline, CEO of @Roivant, discussing how he prepared to step into the CEO role for the first time and his advice to others doing the same.
ow.ly/87fN50N5QxA
Hosted by @rahulc @MeetClora
#biotech #podcast #innovation #technology #healthcare #leadership $ROIV
I could quibble with the word โscrapsโ in the title, but hard to argue with @david_wainer when he suggests the payoff for patients and investors could be large! Thanks for the feature David and @WSJ wsj.com/articles/collecting-โฆ
Matt Gline retweeted
Don't miss CEO @gline on Tuesday Feb 7th at 4pm ET at the #BIOCEO23 panel entitled "Timing the Next Wave of Strategic M&A" alongside @BayerPharma @jpmorgan @DrKazanchyan, moderated by @MichelleF_Davis. Watch this space for updates!
